Stock listing
NASDAQ:GTHX G1 Therapeutics Inc Stock
Follow G1 Therapeutics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:GTHX
$7.15 USD
Close on Sep 17, 2024 · No longer trades
- Lowest – highest close
- $1.12 – $67.97 USDSince May 17, 2017 · lowest Oct 9, 2023 · highest Sep 13, 2018
Delisted NASDAQ:GTHX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:GTHX
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
G1 Therapeutics Inc on 6ix
- Calls
- 14 calls with a replay · 14 with a transcript · latest May 1, 2024
- Decks
- 9 decks · latest Jan 8, 2024
Events
| Call | When | Status |
|---|---|---|
| G1 Therapeutics (GTHX) Q1 2024 Earnings Call | Wed, May 01, 2024 · 8:30 AM ET | Replay |
| G1 Therapeutics (GTHX) Q4 2023 Earnings Call | Wed, Feb 28, 2024 · 8:30 AM ET | Replay |
| G1 Therapeutics (GTHX) Q3 2023 Earnings Call | Wed, Nov 01, 2023 · 8:30 AM ET | Replay |
| G1 Therapeutics (GTHX) Q2 2023 Earnings Call | Wed, Aug 02, 2023 · 8:30 AM ET | Replay |
| G1 Therapeutics (GTHX) Q1 2023 Earnings Call | Wed, May 03, 2023 · 8:30 AM ET | Replay |
| G1 Therapeutics (GTHX) Q4 2022 Earnings Call | Wed, Mar 01, 2023 · 8:30 AM ET | Replay |
| G1 Therapeutics (GTHX) Q3 2022 Earnings Call | Wed, Nov 02, 2022 · 8:30 AM ET | Replay |
| G1 Therapeutics (GTHX) Q2 2022 Earnings Call | Wed, Aug 03, 2022 · 8:30 AM ET | Replay |
| G1 Therapeutics (GTHX) Q1 2022 Earnings Call | Wed, May 04, 2022 · 8:30 AM ET | Replay |
| G1 Therapeutics (GTHX) Q4 2021 Earnings Call | Wed, Feb 23, 2022 · 8:30 AM ET | Replay |
All 14 calls
| Call | When | Status |
|---|---|---|
| G1 Therapeutics (GTHX) Q3 2021 Earnings Call | Wed, Nov 03, 2021 · 8:30 AM ET | Replay |
| G1 Therapeutics (GTHX) Q2 2021 Earnings Call | Wed, Aug 04, 2021 · 4:30 PM ET | Replay |
| G1 Therapeutics (GTHX) Q1 2021 Earnings Call | Wed, May 05, 2021 · 4:30 PM ET | Replay |
| G1 Therapeutics (GTHX) Q4 2020 Earnings Call | Wed, Feb 24, 2021 · 4:30 PM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| 42nd Annual J.P. Morgan Healthcare Conference (January 2024) | Conference | 31 slides | Jan 8, 2024 |
| 41st Annual J.P. Morgan Healthcare Conference (January 2023) | Conference | 37 slides | Jan 9, 2023 |
| 40th Annual J.P. Morgan Healthcare Conference 2022 | Conference | 32 slides | Jan 10, 2022 |
| Investor Presentation (February 2021) | Investor deck | 38 slides | Feb 16, 2021 |
| 39th Annual J.P. Morgan Healthcare Conference 2021 | Conference | 34 slides | Jan 11, 2021 |
| 38th Annual J.P. Morgan Healthcare Conference (January 2020) | Conference | 31 slides | Jan 13, 2020 |
| Investor Day (October 2019) | Investor day | 58 slides | Oct 1, 2019 |
| Investor Presentation (November 2017) | Investor deck | 42 slides | Nov 13, 2017 |
| Wedbush PacGrow Healthcare Conference 2017 | Conference | 41 slides | Aug 17, 2017 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Alicia Secor Other companies: Zevra Therapeutics, Inc. (Director, Audit Committee, Compensation Committee · Since at least Dec 2, 2025); Orchard Therapeutics PLC (Director · Jan 1, 2020 – Jan 24, 2024 · Past); GW Pharmaceuticals plc (Director · Oct 1, 2018 – May 5, 2021 · Past); Juniper Pharmaceuticals Inc (President and CEO, Director · Aug 1, 2016 – Aug 14, 2018 · Past); Larimar Therapeutics, Inc. (Chief Commercial Officer · Mar 31, 2016 – Mar 31, 2016 · Past) | Director · Jun 17, 2021 – Sep 18, 2024 · Past |
| Garry A Nicholson Other companies: TScan Therapeutics, Inc. (Director · Since at least Jun 12, 2024); Day One Biopharmaceuticals Inc (Director · Since at least Sep 12, 2022); NextCure, Inc. (Director · Jun 24, 2021 – Jun 22, 2023 · Past); Turning Point Therapeutics Inc (Director · Jun 2, 2021 – Aug 17, 2022 · Past); Five Prime Therapeutics Inc (Director · Apr 16, 2021 – Apr 16, 2021 · Past) | Director · Jun 17, 2021 – Sep 18, 2024 · Past |
| Tyrell J. Rivers Other companies: ADC Therapeutics SA (Non-Executive Director · Since at least Jan 2, 2024); Viela Bio Inc (Director · Oct 2, 2019 – Mar 15, 2021 · Past); PhaseBio Pharmaceuticals Inc (Director · Oct 17, 2018 – Oct 17, 2018 · Past) | Director · May 16, 2017 – May 16, 2017 · Past |
| Christy L Shaffer Other companies: CalciMedica, Inc. (Director · Sep 24, 2020 – Mar 23, 2023 · Past); Clearside Biomedical Inc (Director · Jun 1, 2016 – Jun 20, 2024 · Past) | Director · May 16, 2017 – Nov 30, 2017 · Past |
| James S Hanson Other companies: Fortrea Holdings Inc. (General Counsel · Since at least Jun 9, 2023) | General Counsel · Jun 25, 2018 – Jan 3, 2023 · Past |
| Jennifer K Moses Other companies: Viridian Therapeutics, Inc. (Director · Since at least Jul 14, 2021) | CFO · Jan 2, 2018 – Jan 3, 2023 · Past |
| Mark A. Velleca Other companies: Black Diamond Therapeutics, Inc. (Chief Executive Officer · Since at least Aug 9, 2021) | Director · May 16, 2017 – Aug 8, 2023 · Past |
| Andrew Perry | Chief Commercial Officer · Aug 16, 2021 – Sep 18, 2024 · Past |
| Mark Avagliano | Chief Business Officer · Jul 29, 2019 – Sep 18, 2024 · Past |
| Norman Sharpless | Director · Jul 22, 2022 – Sep 18, 2024 · Past |
All 11 people
| Person | Seat |
|---|---|
| Soma Gupta | Chief Commercial Officer · Mar 31, 2020 – Jan 4, 2021 · Past |
Log in to ask 6ix AI your own questions about G1 Therapeutics Inc.